Position in TLRY
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$118,963
-$612 QoQ
Shares Held
18,387
+38.9% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 54%
Shared 0%
None 46%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Pictet Asset Management Holding SA holds $649,006,825 across 25 Drug Manufacturers - Specialty & Generic names. TLRY ranks #24 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,924,600 | $227,506,966 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
309,220 | $183,361,275 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
602,643 | $79,392,188 | |
| 4 | VTRS |
Viatris Inc
|
2,645,328 | $35,738,381 | |
| 5 | ALKS |
Alkermes plc.
|
942,184 | $33,315,626 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
623,288 | $30,011,317 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
450,764 | $23,299,991 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
580,428 | $17,482,491 |
All Filings in TLRY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $118,963 | 18,387 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $119,575 | 13,242 | Shares | Sole | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||